BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14642311)

  • 1. Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice.
    Breganó JW; Picão RC; Graça VK; Menolli RA; Itow Jankevicius S; Pinge Filho P; Jankevicius JV
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):257-64. PubMed ID: 14642311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV
    Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral exposure to Phytomonas serpens attenuates thrombocytopenia and leukopenia during acute infection with Trypanosoma cruzi.
    da Silva RV; Malvezi AD; Augusto Lda S; Kian D; Tatakihara VL; Yamauchi LM; Yamada-Ogatta SF; Rizzo LV; Schenkman S; Pinge-Filho P
    PLoS One; 2013; 8(7):e68299. PubMed ID: 23844182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sera of chagasic patients react with antigens from the tomato parasite Phytomonas serpens.
    Graça-de Souza VK; Monteiro-Góes V; Manque P; Souza TA; Corrêa PR; Buck GA; Ávila AR; Yamauchi LM; Pinge-Filho P; Goldenberg S; Krieger MA; Yamada-Ogatta SF
    Biol Res; 2010; 43(2):233-41. PubMed ID: 21031268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights about cross-reactive epitopes of six trypanosomatid genera revealed that Crithidia and Leptomonas have antigenic similarity to L. (L.) chagasi.
    Ferreira LR; Kesper N; Teixeira MM; Laurenti MD; Barbieri CL; Lindoso JA; Umezawa ES
    Acta Trop; 2014 Mar; 131():41-6. PubMed ID: 24275757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.
    Reis-Cunha JL; Mendes TA; de Almeida Lourdes R; Ribeiro DR; Machado-de-Avila RA; de Oliveira Tavares M; Lemos DS; Câmara AC; Olórtegui CC; de Lana M; da Cunha Galvão LM; Fujiwara RT; Bartholomeu DC
    PLoS One; 2014; 9(9):e106304. PubMed ID: 25225853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
    Saldaña A; Sousa OE; Orn A
    Scand J Immunol; 1995 Dec; 42(6):644-50. PubMed ID: 8552988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytomonas serpens: immunological similarities with the human trypanosomatid pathogens.
    Santos AL; d'Avila-Levy CM; Elias CG; Vermelho AB; Branquinha MH
    Microbes Infect; 2007 Jul; 9(8):915-21. PubMed ID: 17556002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity between Trypanosoma cruzi and insect trypanosomatids as a basis for the diagnosos of Chagas' disease.
    Lopes JD; Caulada Z; Barbieri CL; Camargo EP
    Am J Trop Med Hyg; 1981 Nov; 30(6):1183-8. PubMed ID: 6798889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
    Basso B; Moretti ER; Vottero-Cima E
    Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exoantigens of Trypanosoma cruzi. I. Conditions for their detection and immunogenic properties in experimental infections.
    Moretti ER; Basso B; Vottero-Cima E
    J Protozool; 1985 Feb; 32(1):150-3. PubMed ID: 3921695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Trypanosoma cruzi induced by immunization with antigens isolated by affinity chromatography.
    Araujo FG
    Braz J Med Biol Res; 1984; 17(2):157-64. PubMed ID: 6440611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: transfer of protection by lymph node cells obtained from mice immunized with exoantigens of pI 4.5.
    Gruppi A; Cerban F; Pistoresi-Palencia MC; Vottero-Cima E
    Exp Parasitol; 1995 May; 80(3):382-9. PubMed ID: 7537218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
    Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
    Taibi A; Espinoza AG; Ouaissi A
    Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.